{"id":139187,"date":"2026-07-03T18:04:50","date_gmt":"2026-07-03T12:34:50","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=139187"},"modified":"2026-07-03T18:04:52","modified_gmt":"2026-07-03T12:34:52","slug":"global-health-q1-results-2027-preview","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/","title":{"rendered":"Global Health Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Global Health CMP Rs.1,360. Q1 FY27E revenue Rs.1,225-1,410 Cr. PAT estimate Rs.195-249 Cr. 12-month target Rs.1,632-1,808.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/stocks\/medanta\/global-health-ltd-share-price-today\">Global Health<\/a> Q1 Results FY27 is coming into focus as investors position ahead of the July-August 2026 results season, with Global Health shares trading at Rs.1,360 against a market capitalisation of Rs.36,177 Cr and a price-to-earnings multiple of 65.3. As a healthcare services name on the NSE and BSE, Global Health enters the Global Health Q1 Results FY27 print with the Street watching revenue momentum, margin trajectory and management commentary on FY27 guidance.<\/p>\n<p>This Global Health Q1 Results FY27 preview is built on a trailing-growth framework applied to the company&#8217;s Q1 FY26 base of Rs.1,051 Cr revenue and Rs.159 Cr net profit, using the most recent year-on-year growth signal from Q4 FY26. This Q1 prediction is a Uniresearch trailing-growth projection, not a formal analyst estimate, and should be read alongside the company&#8217;s own guidance once released.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=global-health-q1-fy27\"><strong>Get Free Investment Predictions and Global Health Research at Univest<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#About_Global_Health\" title=\"About Global Health\">About Global Health<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#Global_Health_Q1_FY27_Estimates\" title=\"Global Health Q1 FY27 Estimates\">Global Health Q1 FY27 Estimates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#Key_Catalysts_to_Watch\" title=\"Key Catalysts to Watch\">Key Catalysts to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#1_Occupancy_and_ARPOB_Trends\" title=\"1. Occupancy and ARPOB Trends\">1. Occupancy and ARPOB Trends<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#2_Capacity_Addition\" title=\"2. Capacity Addition\">2. Capacity Addition<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#3_Case_Mix_Improvement\" title=\"3. Case Mix Improvement\">3. Case Mix Improvement<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#Key_Risks_to_the_Global_Health_Q1_Results_FY27_Outlook\" title=\"Key Risks to the Global Health Q1 Results FY27 Outlook\">Key Risks to the Global Health Q1 Results FY27 Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#Q4_FY26_Performance_Context_for_the_Global_Health_Q1_Results_FY27_Print\" title=\"Q4 FY26 Performance Context for the Global Health Q1 Results FY27 Print\">Q4 FY26 Performance Context for the Global Health Q1 Results FY27 Print<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#Technical_Analysis_Ahead_of_Global_Health_Q1_Results_FY27\" title=\"Technical Analysis Ahead of Global Health Q1 Results FY27\">Technical Analysis Ahead of Global Health Q1 Results FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#Share_Price_Target_Based_on_the_Global_Health_Q1_Results_FY27_Outlook\" title=\"Share Price Target Based on the Global Health Q1 Results FY27 Outlook\">Share Price Target Based on the Global Health Q1 Results FY27 Outlook<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#3-6_Month_Target\" title=\"3-6 Month Target\">3-6 Month Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#12-Month_Target\" title=\"12-Month Target\">12-Month Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#FY27-28_Outlook\" title=\"FY27-28 Outlook\">FY27-28 Outlook<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#What_to_Watch_in_the_Global_Health_Q1_Results_FY27_Print\" title=\"What to Watch in the Global Health Q1 Results FY27 Print\">What to Watch in the Global Health Q1 Results FY27 Print<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#Conclusion_on_Global_Health_Q1_Results_FY27\" title=\"Conclusion on Global Health Q1 Results FY27\">Conclusion on Global Health Q1 Results FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#FAQs_on_Global_Health_Q1_Results_FY27\" title=\"FAQs on Global Health Q1 Results FY27\">FAQs on Global Health Q1 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#When_are_Global_Health_Q1_FY27_results_expected\" title=\"When are Global Health Q1 FY27 results expected?\">When are Global Health Q1 FY27 results expected?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#What_is_the_Global_Health_Q1_FY27_revenue_estimate\" title=\"What is the Global Health Q1 FY27 revenue estimate?\">What is the Global Health Q1 FY27 revenue estimate?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#What_is_the_Global_Health_share_price_target\" title=\"What is the Global Health share price target?\">What is the Global Health share price target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#Is_Global_Health_a_good_buy_before_Q1_FY27_results\" title=\"Is Global Health a good buy before Q1 FY27 results?\">Is Global Health a good buy before Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#What_should_investors_watch_in_Global_Healths_Q1_FY27_results\" title=\"What should investors watch in Global Health&#8217;s Q1 FY27 results?\">What should investors watch in Global Health&#8217;s Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/global-health-q1-results-2027-preview\/#Where_can_I_track_Global_Health_share_price_live\" title=\"Where can I track Global Health share price live?\">Where can I track Global Health share price live?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Global_Health\"><\/span><strong>About Global Health<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Global Health (NSE: MEDANTA) operates in the healthcare services space and is tracked on Univest under its NSE and BSE listings. Ahead of the Global Health Q1 Results FY27 print, the company&#8217;s Q4 FY26 base shows revenue of Rs.1,196 Cr and net profit of Rs.142 Cr, forming the base against which the Global Health Q1 Results FY27 estimates in this article are built. This Global Health Q1 Results FY27 snapshot is intended as a starting point for research, not a substitute for the company&#8217;s own disclosures.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Global_Health_Q1_FY27_Estimates\"><\/span><strong>Global Health Q1 FY27 Estimates<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse;\">\n<thead>\n<tr style=\"background: #F0F2F5;\">\n<th style=\"padding: 8px; text-align: left; border: 1px solid #DDD;\">Metric<\/th>\n<th style=\"padding: 8px; text-align: right; border: 1px solid #DDD;\">Q1 FY27E (Range)<\/th>\n<th style=\"padding: 8px; text-align: right; border: 1px solid #DDD;\">Q1 FY26 Actual<\/th>\n<th style=\"padding: 8px; text-align: right; border: 1px solid #DDD;\">YoY Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #F9F9F9;\">\n<td style=\"padding: 8px; border: 1px solid #DDD;\">Revenue (Rs. Cr)<\/td>\n<td style=\"padding: 8px; text-align: right; border: 1px solid #DDD;\">1,225-1,410<\/td>\n<td style=\"padding: 8px; text-align: right; border: 1px solid #DDD;\">1,051<\/td>\n<td style=\"padding: 8px; text-align: right; border: 1px solid #DDD;\">+25.3%<\/td>\n<\/tr>\n<tr style=\"background: #FFFFFF;\">\n<td style=\"padding: 8px; border: 1px solid #DDD;\">Net Profit \/ PAT (Rs. Cr)<\/td>\n<td style=\"padding: 8px; text-align: right; border: 1px solid #DDD;\">195-249<\/td>\n<td style=\"padding: 8px; text-align: right; border: 1px solid #DDD;\">159<\/td>\n<td style=\"padding: 8px; text-align: right; border: 1px solid #DDD;\">+39.7%<\/td>\n<\/tr>\n<tr style=\"background: #F9F9F9;\">\n<td style=\"padding: 8px; border: 1px solid #DDD;\">Results Date<\/td>\n<td style=\"padding: 8px; text-align: right; border: 1px solid #DDD;\" colspan=\"3\">July-August 2026 (indicative)<\/td>\n<\/tr>\n<tr style=\"background: #FFFFFF;\">\n<td style=\"padding: 8px; border: 1px solid #DDD;\">12-Month Target (Uniresearch Estimate)<\/td>\n<td style=\"padding: 8px; text-align: right; border: 1px solid #DDD;\" colspan=\"3\">Rs.1,632-1,808<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/sebi-registered-investment-advisor-india\"><strong>Univest, a SEBI-Registered Investment Advisor, Tracks Global Health Ahead of Q1 FY27 Results<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Catalysts_to_Watch\"><\/span><strong>Key Catalysts to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_Occupancy_and_ARPOB_Trends\"><\/span><strong>1. Occupancy and ARPOB Trends<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Occupancy and ARPOB improvement across hospital and diagnostic networks is one of the primary variables that analysts are tracking ahead of Global Health&#8217;s Q1 FY27 results and FY27 guidance. The market&#8217;s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Global Health share price target or faces renewed pressure.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Capacity_Addition\"><\/span><strong>2. Capacity Addition<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Capacity addition through new beds or centres supporting medium-term growth is one of the primary variables that analysts are tracking ahead of Global Health&#8217;s Q1 FY27 results and FY27 guidance. The market&#8217;s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Global Health share price target or faces renewed pressure.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Case_Mix_Improvement\"><\/span><strong>3. Case Mix Improvement<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Case mix improvement toward higher-margin specialties aiding profitability is one of the primary variables that analysts are tracking ahead of Global Health&#8217;s Q1 FY27 results and FY27 guidance. The market&#8217;s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Global Health share price target or faces renewed pressure.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Global Health&#8217;s live price and Q1 FY27 result updates.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_Global_Health_Q1_Results_FY27_Outlook\"><\/span><strong>Key Risks to the Global Health Q1 Results FY27 Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Slower occupancy ramp-up in newly added capacity affecting near-term margins.<\/li>\n<li>Regulatory changes to pricing or insurance reimbursement norms.<\/li>\n<li>Talent cost inflation for specialist doctors and clinical staff.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Q4_FY26_Performance_Context_for_the_Global_Health_Q1_Results_FY27_Print\"><\/span><strong>Q4 FY26 Performance Context for the Global Health Q1 Results FY27 Print<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Global Health closed Q4 FY26 with revenue of Rs.1,196 Cr and net profit of Rs.142 Cr, a year-on-year revenue change of +25.3% and PAT change of +39.7%. This base underpins the Global Health Q1 Results FY27 projection used in this preview and should be read alongside the company&#8217;s own Global Health Q1 Results FY27 commentary once reported.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Technical_Analysis_Ahead_of_Global_Health_Q1_Results_FY27\"><\/span><strong>Technical Analysis Ahead of Global Health Q1 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Global Health shares last traded at Rs.1,360. For the current 52-week high and low, support and resistance levels, investors should check the live chart on the Univest app or the NSE website, since these levels move intraday and are not reproduced here to avoid stale data.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Share_Price_Target_Based_on_the_Global_Health_Q1_Results_FY27_Outlook\"><\/span><strong>Share Price Target Based on the Global Health Q1 Results FY27 Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"3-6_Month_Target\"><\/span><strong>3-6 Month Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Over a 3-6 month horizon, the Global Health Q1 Results FY27 trailing-growth framework points to a range of Rs.1,424-1,533 for Global Health, contingent on the Global Health Q1 Results FY27 print matching or beating the trailing growth trend.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12-Month_Target\"><\/span><strong>12-Month Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month target (Uniresearch estimate) tied to this Global Health Q1 Results FY27 view for Global Health works out to Rs.1,632-1,808, built on the same trailing revenue growth trend and current valuation multiple. Tracking with a constructive bias is how Univest research categorises the stock heading into Global Health Q1 Results FY27, not a formal Buy or Sell call.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FY27-28_Outlook\"><\/span><strong>FY27-28 Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Looking out to FY27-28, a sustained continuation of the growth trajectory implied by this Global Health Q1 Results FY27 analysis would put Global Health in a Rs.1,863-2,108 range, though this is sensitive to sector-wide demand, cost trends and any change in the company&#8217;s competitive position.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_to_Watch_in_the_Global_Health_Q1_Results_FY27_Print\"><\/span><strong>What to Watch in the Global Health Q1 Results FY27 Print<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Revenue and PAT versus the Global Health Q1 Results FY27 estimate range in this preview.<\/li>\n<li>Management commentary on FY27 growth guidance and margin trajectory relevant to the Global Health Q1 Results FY27 narrative.<\/li>\n<li>Occupancy and ARPOB improvement across hospital and diagnostic networks<\/li>\n<li>Slower occupancy ramp-up in newly added capacity affecting near-term margins<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_on_Global_Health_Q1_Results_FY27\"><\/span><strong>Conclusion on Global Health Q1 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Global Health enters the Q1 FY27 results season trading at Rs.1,360, with the 12-month Uniresearch target range of Rs.1,632-1,808 reflecting a tracking with a constructive bias stance. Investors tracking the Global Health Q1 Results FY27 print should watch the catalysts and risks above and consult a SEBI-registered advisor before making investment decisions around the results.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Global_Health_Q1_Results_FY27\"><\/span><strong>FAQs on Global Health Q1 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"When_are_Global_Health_Q1_FY27_results_expected\"><\/span><strong>When are Global Health Q1 FY27 results expected?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Ans. Global Health&#8217;s Q1 FY27 results are expected in the July-August 2026 window, in line with the broader NSE and BSE results season for the quarter ending June 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Global_Health_Q1_FY27_revenue_estimate\"><\/span><strong>What is the Global Health Q1 FY27 revenue estimate?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Ans. The Uniresearch trailing-growth estimate for Global Health&#8217;s Q1 FY27 revenue is Rs.1,225-1,410 Cr, based on the Q1 FY26 base of Rs.1,051 Cr.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Global_Health_share_price_target\"><\/span><strong>What is the Global Health share price target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Ans. The 12-month Uniresearch estimate for Global Health share price target is Rs.1,632-1,808, based on trailing growth and current valuation multiples.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Global_Health_a_good_buy_before_Q1_FY27_results\"><\/span><strong>Is Global Health a good buy before Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Ans. Global Health is tracking with a constructive bias heading into Q1 FY27 results. Investors should weigh the catalysts and risks in this article and consult a SEBI-registered advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_watch_in_Global_Healths_Q1_FY27_results\"><\/span><strong>What should investors watch in Global Health&#8217;s Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Ans. Key items include revenue and PAT versus estimates, management commentary on FY27 guidance, and occupancy and ARPOB improvement across hospital and diagnostic networks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Global_Health_share_price_live\"><\/span><strong>Where can I track Global Health share price live?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Ans. Global Health share price can be tracked live on the Univest app and website, along with research updates from SEBI-registered analysts.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Global Health Q1 Results FY27 preview: revenue and PAT estimates, results date, key catalysts, risks and share price target.<\/p>\n","protected":false},"author":35,"featured_media":139942,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-139187","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1783082094:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["80"],"rank_math_title":["Global Health Q1 FY27 Results Preview"],"rank_math_description":["Global Health Q1 Results FY27 preview: revenue estimate, PAT outlook, results date, key catalysts, risks and share price target based on trailing growth analysis."],"rank_math_focus_keyword":["Global Health Q1"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["139942"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["23440"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Global-Health-Q1-Results.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/139187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=139187"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/139187\/revisions"}],"predecessor-version":[{"id":139943,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/139187\/revisions\/139943"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/139942"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=139187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=139187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=139187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}